PAM
AEON.WS

Panagora Asset Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Panagora Asset Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-264
Closed – – 2471
2021
Q2 		$0 Buy
+264
New +$200 ﹤0.01% 2996

Other funds holding AEON.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Panagora Asset Management's AEON.WS Position: Q3 2021 in Review

Panagora Asset Management sold out of AEON Biopharma Inc (AEON.WS) in Q3 2021, closing a stake of 264 shares.

Panagora Asset Management first reported a position in AEON.WS in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 48 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2021.

  • Panagora Asset Management reported no remaining AEON Biopharma Inc position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 264 AEON Biopharma Inc shares in Q3 2021.
  • Panagora Asset Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 1 quarter.
  • Panagora Asset Management's AEON Biopharma Inc position peaked at $0 in Q2 2021.
  • 48 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.